Suppr超能文献

放疗对吞咽相关结构的影响:头颈部癌患者三维适形放疗(3D-CRT)与调强放疗(IMRT)技术的剂量学和临床对比分析

Impact of Radiation on Dysphagia-Related Structures: A Dosimetric and Clinical Comparative Analysis of Three-Dimensional Conformal Radiotherapy (3D-CRT) and Intensity-Modulated Radiation Therapy (IMRT) Techniques in Patients With Head and Neck Cancer.

作者信息

Manam Surendra, Teja Ravi, Pb Anand Rao, Azharuddin S K

机构信息

Radiation Oncology, GSL Medical College and General Hospital, Rajahmundry, IND.

Medical Oncology, GSL Medical College and General Hospital, Rajahmundry, IND.

出版信息

Cureus. 2024 Apr 14;16(4):e58276. doi: 10.7759/cureus.58276. eCollection 2024 Apr.

Abstract

Introduction Head and neck squamous cell carcinoma (HNSCC) is a significant health concern in India, with around one million new cases annually. The prevalence of HNSCC is notably high in Asia, especially in India, due to habits like tobacco chewing, betel nut usage, and alcohol consumption. Treatment typically involves a combination of surgery, radiation, chemotherapy, and biological therapy, aiming for tumor control while preserving function and quality of life. However, survivors often face long-term side effects like difficulty swallowing, leading to complications such as aspiration pneumonia. Intensity-modulated radiotherapy (IMRT) has shown promise in improving outcomes by sparing critical swallowing structures. Efforts to minimize radiation-related dysphagia are crucial for enhancing patients' quality of life post-treatment. Our study focuses on examining dosimetric parameters associated with dysphagia aspiration, alongside evaluating dysphagia grades in both treatment groups using the RTOG scale. Material and methods Patients with histologically confirmed non-metastatic head and neck carcinomas were included in our study in November 2018-April 2020. A total of 56 patients were taken into our study with 28 in each arm. They underwent radical radiotherapy (RT) with a total dose of 66-70 Gy, with or without concurrent chemotherapy, meeting specific inclusion criteria and excluding those receiving reirradiation or with distant metastasis. Patients were divided into two groups: Group I received three-dimensional conformal radiotherapy (3D-CRT), and Group II received IMRT. Treatment planning involved immobilization, CT imaging, delineation of target volumes and organs at risk, and contouring of swallowing structures. Dose-volume histogram parameters (mean dose, maximum dose, V30, V70, V80, D50, and D80) were used to assess mean dose to swallowing structures outside the planning target volume (PTV), with a mean dose constraint of 50 Gy. Dysphagia was evaluated using the RTOG criteria at baseline, during treatment, and six months post-treatment. Statistical analysis was performed using SPSS, with significance set at p < 0.05. Results In our study, the mean age at presentation differed slightly between the IMRT and 3D-CRT arms: 58 years versus 55 years, respectively. A higher proportion of patients in both arms experienced symptoms for three to six months, with 53.6% in 3D-CRT and 42.9% in IMRT. Stage distribution varied, with IV being most common in 3D-CRT and stage II in IMRT. Approximately 56% of patients in both groups had a history of smoking. Significant differences were observed in spinal cord dose between 3DCRT and IMRT techniques (p < 0.001). Similarly, a significant difference was found in the mean dose received by dysphagia aspiration-related structures (DARSs) between the 3D-CRT and IMRT arms (p = 0.04). Patients in the IMRT arm exhibited superior dysphagia grades compared to those in the 3D-CRT arm, with statistical significance observed in the third month (p = 0.008) and sixth month (p = 0.048). Conclusion Our study found a notable decrease in the mean DARS dose and reduced dysphagia severity at three and six months in the IMRT group compared to the 3D-CRT group. However, due to the diverse study population, establishing a definitive correlation between the DARS dose and dysphagia severity was challenging. Future large-scale studies are needed to validate these findings for improved preservation of DARS structures.

摘要

引言

头颈部鳞状细胞癌(HNSCC)是印度一个重大的健康问题,每年新增病例约达100万。由于嚼烟、食用槟榔和饮酒等习惯,HNSCC在亚洲的患病率显著较高,尤其是在印度。治疗通常包括手术、放疗、化疗和生物治疗相结合,旨在控制肿瘤的同时保留功能和生活质量。然而,幸存者常常面临诸如吞咽困难等长期副作用,进而导致吸入性肺炎等并发症。调强放疗(IMRT)已显示出通过保护关键吞咽结构来改善治疗效果的前景。尽量减少与放疗相关的吞咽困难对于提高患者治疗后的生活质量至关重要。我们的研究重点是检查与吞咽困难误吸相关的剂量学参数,并使用美国放射肿瘤学协作组(RTOG)量表评估两个治疗组的吞咽困难分级。

材料与方法

2018年11月至2020年4月期间,组织学确诊的非转移性头颈部癌患者被纳入我们的研究。我们共纳入了56例患者,每组28例。他们接受了总剂量为66 - 70 Gy的根治性放疗(RT),有或无同步化疗,符合特定纳入标准,排除接受再程放疗或有远处转移的患者。患者被分为两组:第一组接受三维适形放疗(3D - CRT),第二组接受IMRT。治疗计划包括固定、CT成像、靶区体积和危及器官的勾画以及吞咽结构的轮廓勾画。剂量体积直方图参数(平均剂量、最大剂量、V30、V70、V80、D50和D80)用于评估计划靶区(PTV)外吞咽结构的平均剂量,平均剂量约束为50 Gy。在基线、治疗期间和治疗后六个月使用RTOG标准评估吞咽困难。使用SPSS进行统计分析,显著性设定为p < 0.05。

结果

在我们的研究中,IMRT组和3D - CRT组的平均就诊年龄略有差异:分别为58岁和55岁。两组中较高比例的患者出现症状三至六个月,3D - CRT组为53.6%,IMRT组为42.9%。分期分布有所不同,3D - CRT组中IV期最常见,IMRT组中II期最常见。两组中约56%的患者有吸烟史。3DCRT和IMRT技术在脊髓剂量方面存在显著差异(p < 0.001)。同样,3D - CRT组和IMRT组在吞咽困难误吸相关结构(DARSs)接受的平均剂量方面也存在显著差异(p = 0.04)。与3D - CRT组相比,IMRT组患者的吞咽困难分级更优,在第三个月(p = 0.008)和第六个月(p = 0.048)观察到统计学显著性。

结论

我们的研究发现,与3D - CRT组相比,IMRT组的平均DARS剂量显著降低,且在三个月和六个月时吞咽困难严重程度减轻。然而,由于研究人群的多样性,确定DARS剂量与吞咽困难严重程度之间的确切相关性具有挑战性。需要未来的大规模研究来验证这些发现,以更好地保护DARS结构。

相似文献

6
Identifying organs at risk for radiation-induced late dysphagia in head and neck cancer patients.
Clin Transl Radiat Oncol. 2019 Aug 30;19:87-95. doi: 10.1016/j.ctro.2019.08.005. eCollection 2019 Nov.

本文引用的文献

1
Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.
J Clin Oncol. 2015 Oct 10;33(29):3243-50. doi: 10.1200/JCO.2015.61.2358. Epub 2015 Sep 8.
2
Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer.
Cancer. 2015 Apr 15;121(8):1303-11. doi: 10.1002/cncr.29207. Epub 2014 Dec 23.
3
Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?
Oral Oncol. 2014 Dec;50(12):1182-7. doi: 10.1016/j.oraloncology.2014.09.009. Epub 2014 Oct 14.
4
Revisiting unnecessary larynx irradiation with whole-neck IMRT.
Pract Radiat Oncol. 2011 Jan-Mar;1(1):27-32. doi: 10.1016/j.prro.2010.09.002. Epub 2011 Jan 14.
7
Delineation of organs at risk involved in swallowing for radiotherapy treatment planning.
Radiother Oncol. 2011 Dec;101(3):394-402. doi: 10.1016/j.radonc.2011.05.015. Epub 2011 Jun 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验